关注
Maryam Ibrahim
Maryam Ibrahim
Massachusetts General Hospital
在 mgh.harvard.edu 的电子邮件经过验证
标题
引用次数
引用次数
年份
MicroRNAs as potential pharmaco-targets in ischemia-reperfusion injury compounded by diabetes
H Dehaini, H Awada, A El-Yazbi, FA Zouein, K Issa, AA Eid, M Ibrahim, ...
Cells 8 (2), 152, 2019
512019
Baseline procalcitonin as a predictor of bacterial infection and clinical outcomes in COVID-19: A case-control study
NJ Atallah, HM Warren, MB Roberts, RH Elshaboury, MR Bidell, ...
PloS one 17 (1), e0262342, 2022
402022
Genomic Assays in Node Positive Breast Cancer Patients: A Review. Front
M Bou Zerdan, M Ibrahim, C El Nakib, R Hajjar, HI Assi
Oncol 10, 3461, 2021
242021
The empirical dietary inflammatory pattern score and the risk of nonalcoholic fatty liver disease and cirrhosis.
MK Ibrahim, RM Wilechansky, PK Challa, X Zhang, E Giovannucci, ...
Hepatology Communications 7 (10), e0263-e0263, 2023
82023
Effect of combined tobacco use and type 2 diabetes mellitus on prevalent fibrosis in patients with MASLD
O Balogun, JY Wang, ES Shaikh, K Liu, S Stoyanova, ZN Memel, ...
Hepatology Communications 7 (11), e0300, 2023
62023
Arrhythmias in Neonates and Infants at a Tertiary Care Center
M Refaat, MM Abohelwa, M Ahmed, A Elgehiny, M Ibrahim, P Zakka, ...
Cureus 13 (1), 2021
42021
Extrahepatic Outcomes of Nonalcoholic Fatty Liver Disease: Nonhepatocellular Cancers
MK Ibrahim, TG Simon, ME Rinella
Clinics in Liver Disease, 2023
32023
ARRHYTHMIAS IN NEONATES AND INFANTS AT A TERTIARY CARE CENTER
M Abohelwa, M Refaat, MA Ahmed, M Ibrahim, A Elgehiny, P Zakka, ...
Journal of the American College of Cardiology 77 (18_Supplement_1), 397-397, 2021
12021
Su1596 HEPATIC STEATOSIS IDENTIFICATION: A COMPREHENSIVE APPROACH USING NATURAL LANGUAGE PROCESSING AND MACHINE LEARNING IN RADIOLOGY REPORTS
O Balogun, ES Shaikh, L Mun, M Michta, MK Ibrahim, EU Anya, KE Corey
Gastroenterology 166 (5), S-1656-S-1657, 2024
2024
Sa1579 TOBACCO USE SYNERGISTICALLY INCREASED THE RISK OF HEPATIC FIBROSIS IN NON-ALCOHOLIC FATTY LIVER DISEASE PATIENTS WITH TYPE 2 DIABETES MELLITUS
O Balogun, ES Shaikh, KT Liu, J Wang, S Stoyanova, H Schultz, ...
Gastroenterology 164 (6), S-1302, 2023
2023
S3342 Inpatient Initiation of Pharmacotherapy for Obesity to Improve Liver Transplant Eligibility: A Case Report
M Ibrahim, M Conrath, G Dicarlo, E Bethea, D Back
Official journal of the American College of Gastroenterology| ACG 117 (10S …, 2022
2022
THE EMPIRICAL DIETARY INFLAMMATORY PATTERN SCORE AND THE RISK OF NAFLD AND CIRRHOSIS
M Ibrahim, RM Wilechansky, PK Challa, X Zhang, E Giovannucci, ...
HEPATOLOGY 76, S712-S713, 2022
2022
THE EMPIRICAL DIETARY INFLAMMATORY PATTERN SCORE AND THE RISK OF CARDIOVASCULAR DISEASE IN PATIENTS WITH NAFLD
M Ibrahim, RM Wilechansky, PK Challa, X Zhang, E Giovannucci, ...
HEPATOLOGY 76, S713-S714, 2022
2022
Genomic Assays in Node Positive Breast Cancer Patients: A Review (vol 10, 609100, 2021)
M Bou Zerdan, M Ibrahim, C El Nakib, R Hajjar, HI Assi
FRONTIERS IN ONCOLOGY 11, 2021
2021
Corrigendum: Genomic Assays in Node Positive Breast Cancer Patients: A Review
M Bou Zerdan, M Ibrahim, C El Nakib, R Hajjar, HI Assi
Frontiers in Oncology 11, 1255, 2021
2021
Arrhythmias in Neonates and Infants at a Tertiary Care Center
A Muacevic, J Adler, M Refaat, M Abohelwa, M Ahmed, A Elgehiny, ...
Cureus 13 (1), 2021
2021
Corrigendum: Genomic Assays in Node Positive Breast Cancer Patients: A Review
M Ibrahim, C El Nakib, R Hajjar, H Assi
Frontiers in Oncology 11, 2021
2021
Genomic Assays in Node Positive Breast Cancer Patients: A Review
MB Zerdan, M Ibrahim, C El Nakib, R Hajjar, HI Assi
Frontiers in Oncology 10, 2020
2020
Extrahepatic and Hepatic Cancers
M Ibrahim, TG Simon
Need-to-Know NAFLD, 183-194, 0
系统目前无法执行此操作,请稍后再试。
文章 1–19